Company: CRL
Filing Date: 2025-02-19
Form Type: 10-K
Source: 0001100682-25-000011
Chunk: 161

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-02-19
Form: 10-K
Item: Item 8
Chunk 161
---
 $739,175 DSA2,451,280 2,615,623 2,447,316 Manufacturing769,332 721,443 789,569 Total revenue$4,049,989 $4,129,409 $3,976,060 Operating Income (Loss)RMS$114,411 $154,666 $160,410 DSA442,510 606,076 532,889 Manufacturing(71,453)88,329 167,084 Segment operating income485,468 849,071 860,383 Unallocated corporate(258,121)(231,810)(209,408)Operating income$227,347 $617,261 $650,975 Other income (expense):Interest income8,575 5,196 780 Interest expense(126,288)(136,710)(59,291)Other income (expense), net(16,520)95,537 30,523 Income before income taxes$93,114 $581,284 $622,987 Capital expenditures and depreciation and amortization (related to both intangible assets and certain assets acquired in business combinations) by reportable segment are as follows:RMSDSAManufacturingUnallocated CorporateConsolidated(in thousands)Capital ExpendituresFiscal Year2024$64,134 $128,356 $38,500 $1,977 $232,967 202352,819 204,891 58,134 2,684 318,528 202244,136 189,563 87,084 3,950 324,733 Depreciation and amortizationFiscal Year2024$73,812 $191,126 $89,964 $6,839 $361,741 202355,570 174,719 79,982 3,853 314,124 202249,274 179,465 72,950 2,181 303,870 Revenue represents sales originating in entities physically located in the identified geographic area. Revenue by geographic area is as follows:U.S.EuropeCanadaAsia PacificOther (1)Consolidated(in thousands)Fiscal Year2024$2,239,977 $1,078,146 $482,093 $196,952 $52,821 $4,049,989 20232